- European indices finished today's session lower, with DAX down 0.1% dragged down by tech stocks.
-
The German economy unexpectedly contracted in Q4, and Spain's inflation accelerated in January from December's 13-month low.
-
The blue-chip Dow Jones is trading 0.30% lower on Monday, while the S&P 500 and Nasdaq 100 fell 0.9% and 1.6%, respectively, as investors braced for an interesting week of earnings with four US megatech companies (Meta, Alphabet, Amazon and Apple) and interest rate decisions from FED, ECB and BoE.
-
Alibaba shares plunged over 7% following news that the Chinese e-commerce giant is moving its headquarters out of the country. Company denied these speculations.
-
Energy commodities are trading under pressure on Monday. Oil prices fell over 2.0% as Russian oil producers have been able to secure export deals despite Western sanctions and price caps on the back of robust demand from Asia.
-
Natgas briefly fell 10.0% and tested $2.56 mark after recent weather forecasts pointed to milder weather across most of the US in the next few days.
-
Gold again pulled back to major support at $1920 amid stronger dollar and elevated treasury yields.
-
Dollar is the best performing currency among G10. Greenback strengthened significantly against antipodean currencies, yen and pound. EURUSD is approaching major support at 1.0835.
-
Selling pressure is visible on the crypto market. Bitcoin fell nearly 5.0% and retreated towards support at $22700, while Ethereum fell from recent highs at $1650 and tested $1525 level.
USDCAD bounced off key support at 1.3300 and launched an impressive recovery move on Monday. If current sentiment prevails, crucial resistance at 1.3410 may be at risk. Source: xStation5
Chart of the day: GBPCHF snaps back on retail sales recovery 🇬🇧 📈 (19.06.2026)
Economic Calendar: Liquidity Overshadowed by Juneteenth (19.06.2026)
Morning Wrap: Asia pulls back on peace skepticism. Tokyo flags yen intervention (19.06.2026)
Daily Summary: Dollar at 1-year high, stocks rebound on renewed risk appetite 🚀 (18.06.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.